Sleep and Activity Monitoring After Thoracic Surgery

Thoracic Surgery Clinical Trial

Official title:

Sleep and Activity Monitoring After Thoracic Surgery

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02927860
• Other study ID #: 16-006864
• Status: Terminated
• Start date: October 2016
• Est. completion date: August 8, 2017

Study information

• Verified date: January 2019
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Show by collecting sleep and activity data, outcomes after thoracic surgery are improved with better sleep and increased activity.

Description:

Little is known about how sleep deprivation affects recovery after thoracic surgery. There is some evidence that in cardiac surgery, sleep disturbance can lead to delayed recovery and mental status changes in the postoperative period. There are no similar reports of studies after thoracic surgery. We think that increased activity after surgery is beneficial for a rapid recovery and prevents blood clots, pneumonia and deconditioning. Without specific data this is difficult to prove.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 5
• Est. completion date: August 8, 2017
• Est. primary completion date: August 8, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• undergoing thoracic surgery at Mayo Clinic Rochester

• expected to stay in hospital for at least 4 days

• signed consent form

Exclusion Criteria:

• Unable to provide consent

Related Conditions & MeSH terms

• Surgery, Thoracic
• Thoracic Surgery

Intervention

Other:
• Fitbit
A FitBit HR monitor will be placed on patients when they arrive on the nursing unit after thoracic surgery. Sleep and activity will be monitored for the duration of the patient's hospitalization and the data from the Fitbit HR device will be downloaded by the study staff to a computer.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Length of Stay		Until discharge, an average of 5 days
Secondary	Incidence of pneumonia while hospitalized		Until discharge, an average of 5 days
Secondary	Incidence of blood clot while hospitalized		Until discharge, an average of 5 days
Secondary	Incidence of deconditioning while hospitalized		Until discharge, an average of 5 days